A Phase 3, Double-blind, Randomized Study of BGB 290 versus Placebo as Maintenance Therapy in Patients with Inoperable Locally Advanced or Metastatic Gastric Cancer that Responded to Platinum-based First-line Chemotherapy

Project: Research

Project Description

NMA HREC Reference Number: HREC/18/MonH/61
NMA SSA Reference Number: SSA/18/MonH/400
Monash Health Ref: RES-18-0000-118A
StatusActive
Effective start/end date6/05/19 → 5/05/24
View all
View less

Keywords

  • clinical trial
  • treatment efficacy
  • gastric cancer